203 related articles for article (PubMed ID: 2453828)
1. Translocated c-myc genes produce chimeric transcripts containing antisense sequences of the immunoglobulin heavy chain locus in mouse plasmacytomas.
Julius MA; Street AJ; Fahrlander PD; Yang JQ; Eisenman RN; Marcu KB
Oncogene; 1988 May; 2(5):469-76. PubMed ID: 2453828
[TBL] [Abstract][Full Text] [Related]
2. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
[TBL] [Abstract][Full Text] [Related]
3. Aberrant class switching juxtaposes c-myc with a middle repetitive element (LINE) and an IgH intron in two spontaneously arising rat immunocytomas.
Pear WS; Nelson SF; Axelson H; Wahlström G; Bazin H; Klein G; Sümegi J
Oncogene; 1988 May; 2(5):499-507. PubMed ID: 3131719
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Ig gene expression by Ig binding factors. Suppression of alpha-H chain and lambda-2-L chain mRNA accumulation in MOPC-315 by IgA-binding factor.
Roman S; Moore JS; Darby C; Müller S; Hoover RG
J Immunol; 1988 May; 140(10):3622-30. PubMed ID: 3129498
[TBL] [Abstract][Full Text] [Related]
5. Transcription of unrearranged Ig H chain genes in human B cell malignancies. Biased expression of genes encoded within the first duplication unit of the Ig H chain locus.
Sideras P; Nilsson L; Islam KB; Quintana IZ; Freihof L; Rosén A; Juliusson G; Hammarström L; Smith CI
J Immunol; 1992 Jul; 149(1):244-52. PubMed ID: 1607657
[TBL] [Abstract][Full Text] [Related]
6. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
[TBL] [Abstract][Full Text] [Related]
7. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents.
Shaughnessy JD; Owens JD; Wiener F; Hilbert DM; Huppi K; Potter M; Mushinski JF
Oncogene; 1993 Nov; 8(11):3111-21. PubMed ID: 8414513
[TBL] [Abstract][Full Text] [Related]
8. Myelomas and lymphomas expressing the Ig gamma 2a H chain gene have similar transcription termination regions.
Flaspohler JA; Milcarek C
J Immunol; 1990 Apr; 144(7):2802-10. PubMed ID: 2108214
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of inactivation of the normal c-myc gene locus in human Burkitt lymphoma cells.
Nishikura K; Murray JM
Oncogene; 1988 May; 2(5):493-8. PubMed ID: 3131718
[TBL] [Abstract][Full Text] [Related]
10. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
Müller JR; Janz S; Potter M
Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
[TBL] [Abstract][Full Text] [Related]
11. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M
Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586
[TBL] [Abstract][Full Text] [Related]
12. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
13. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda.
Axelson H; Panda CK; Silva S; Sugiyama H; Wiener F; Klein G; Sumegi J
Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673
[TBL] [Abstract][Full Text] [Related]
14. Deletional remodeling of c-myc-deregulating chromosomal translocations.
Kovalchuk AL; Müller JR; Janz S
Oncogene; 1997 Nov; 15(19):2369-77. PubMed ID: 9393881
[TBL] [Abstract][Full Text] [Related]
15. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
16. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
Ohno S; Migita S; Murakami S
Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771
[TBL] [Abstract][Full Text] [Related]
17. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
18. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
19. B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching.
Zelazowski P; Carrasco D; Rosas FR; Moorman MA; Bravo R; Snapper CM
J Immunol; 1997 Oct; 159(7):3133-9. PubMed ID: 9317110
[TBL] [Abstract][Full Text] [Related]
20. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
